Patient Square Capital LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ROIVANT SCIENCES LTD(ROIV) | 8,166,047 | 8,166,047 | 0 | 177,203,220 | 226,199,502 | 40.13% | +48,996,282 |
| BELITE BIO INC(BLTE) | 0 | 116,684 | +116,684 | 0 | 18,604,097 | 3.30% | +18,604,097 |
| LEGEND BIOTECH CORP(LEGN) | 0 | 990,000 | +990,000 | 0 | 17,909,100 | 3.18% | +17,909,100 |
| NEKTAR THERAPEUTICS(NKTR) | 0 | 210,000 | +210,000 | 0 | 15,109,500 | 2.68% | +15,109,500 |
| COGENT BIOSCIENCES INC(COGT) | 317,372 | 596,000 | +278,628 | 11,273,053 | 22,940,040 | 4.07% | +11,666,987 |
| MERCK & CO INC(MRK) | 0 | 80,000 | +80,000 | 0 | 9,623,200 | 1.71% | +9,623,200 |
| DBV TECHNOLOGIES S A(DBVT) | 359,050 | 693,534 | +334,484 | 6,882,989 | 14,487,925 | 2.57% | +7,604,936 |
| XENON PHARMACEUTICALS INC(XENE) | 136,500 | 227,000 | +90,500 | 6,117,930 | 13,200,050 | 2.34% | +7,082,120 |
| DEFINIUM THERAPEUTICS INC(DFTX) | 0 | 331,000 | +331,000 | 0 | 6,255,900 | 1.11% | +6,255,900 |
| HARROW INC(HROW) | 7,031 | 165,209 | +158,178 | 344,519 | 5,825,269 | 1.03% | +5,480,750 |
| PROTARA THERAPEUTICS INC | 0 | 1,030,846 | +1,030,846 | 0 | 5,370,708 | 0.95% | +5,370,708 |
| CYTOMX THERAPEUTICS INC. | 0 | 1,085,790 | +1,085,790 | 0 | 5,103,213 | 0.91% | +5,103,213 |
| ARGENX SE(ARGX) | 26,000 | 36,718 | +10,718 | 21,864,700 | 26,813,320 | 4.76% | +4,948,620 |
| PERSPECTIVE THERAPEUTICS INC | 1,132,815 | 1,625,000 | +492,185 | 3,115,241 | 6,776,250 | 1.20% | +3,661,009 |
| ARCUTIS BIOTHERAPEUTICS INC(ARQT) | 210,000 | 400,645 | +190,645 | 6,098,400 | 9,439,196 | 1.67% | +3,340,796 |
| ENLIVEN THERAPEUTICS INC | 308,141 | 200,000 | -108,141 | 4,745,371 | 7,840,000 | 1.39% | +3,094,629 |
| BEONE MEDICINES LTD(ONC) | 69,312 | 80,542 | +11,230 | 21,057,679 | 23,918,558 | 4.24% | +2,860,879 |
| DIANTHUS THERAPEUTICS INC(DNTH) | 150,000 | 93,882 | -56,118 | 6,181,500 | 7,878,577 | 1.40% | +1,697,077 |
| ALLOGENE THERAPEUTICS INC | 4,963,756 | 3,450,000 | -1,513,756 | 6,800,346 | 8,418,000 | 1.49% | +1,617,654 |
| ARCUS BIOSCIENCES INC(RCUS) | 170,000 | 195,000 | +25,000 | 4,051,100 | 4,212,000 | 0.75% | +160,900 |
| ASSEMBLY BIOSCIENCES INC | 127,000 | 136,315 | +9,315 | 4,319,270 | 3,782,741 | 0.67% | -536,529 |
| CELCUITY INC(CELC) | 120,000 | 95,000 | -25,000 | 11,968,800 | 10,843,300 | 1.92% | -1,125,500 |
| PHARVARIS N V | 542,696 | 493,000 | -49,696 | 15,059,814 | 13,927,250 | 2.47% | -1,132,564 |
| MIRUM PHARMACEUTICALS INC(MIRM) | 298,682 | 230,000 | -68,682 | 23,592,891 | 21,247,400 | 3.77% | -2,345,491 |
| KYMERA THERAPEUTICS INC(KYMR) | 139,000 | 100,000 | -39,000 | 10,815,590 | 8,329,000 | 1.48% | -2,486,590 |
| EYEPOINT INC(EYPT) | 780,000 | 795,000 | +15,000 | 14,250,600 | 10,247,550 | 1.82% | -4,003,050 |
| ABIVAX SA(ABVX) | 130,000 | 121,245 | -8,755 | 17,530,500 | 13,500,631 | 2.40% | -4,029,869 |
| AMYLYX PHARMACEUTICALS INC(AMLX) | 350,000 | 0 | -350,000 | 4,228,000 | 0 | — | -4,228,000 |
| SPYRE THERAPEUTICS INC(SYRE) | 150,000 | 1,000 | -149,000 | 4,914,000 | 50,440 | 0.01% | -4,863,560 |
| AVALO THERAPEUTICS INC | 311,966 | 0 | -311,966 | 5,665,303 | 0 | — | -5,665,303 |
| DISC MEDICINE INC(IRON) | 74,000 | 0 | -74,000 | 5,876,340 | 0 | — | -5,876,340 |
| OCULAR THERAPEUTIX INC(OCUL) | 490,000 | 0 | -490,000 | 5,948,600 | 0 | — | -5,948,600 |
| LIQUIDIA CORPORATION(LQDA) | 227,000 | 0 | -227,000 | 7,829,230 | 0 | — | -7,829,230 |
| TERNS PHARMACEUTICALS INC | 320,000 | 0 | -320,000 | 12,928,000 | 0 | — | -12,928,000 |
| INSMED INC(INSM) | 267,000 | 157,500 | -109,500 | 46,468,680 | 25,754,400 | 4.57% | -20,714,280 |